These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 955357)

  • 21. Porphyria. Basic science aspects.
    Bickers DR
    Dermatol Clin; 1986 Apr; 4(2):277-90. PubMed ID: 3955898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intermittent acute porphyria. Hepatic ultrastructural study].
    Gaultier M; Gervais P; Bescol J; Conso F; Aubry P; Guillam C
    Ann Med Interne (Paris); 1974; 125(6-7):539-46. PubMed ID: 4440969
    [No Abstract]   [Full Text] [Related]  

  • 23. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary hepatic porphyrias.
    Meyer UA; Schmid R
    Fed Proc; 1973 Jun; 32(6):1649-55. PubMed ID: 4710876
    [No Abstract]   [Full Text] [Related]  

  • 25. The porphyrias: a review.
    Elder GH; Gray CH; Nicholson DC
    J Clin Pathol; 1972 Dec; 25(12):1013-33. PubMed ID: 4570617
    [No Abstract]   [Full Text] [Related]  

  • 26. Porphyrin biosynthesis. Enhancement of the fractional catabolic rate of microsomal haem in chemically induced porphyria.
    Meyer UA; Marver HS
    S Afr Med J; 1971 Sep; ():175-7. PubMed ID: 5150273
    [No Abstract]   [Full Text] [Related]  

  • 27. [Porphyria].
    Ho TT
    Ned Tijdschr Geneeskd; 1972 Jun; 116(25):1048-57. PubMed ID: 4556517
    [No Abstract]   [Full Text] [Related]  

  • 28. Porphyria.
    Wiegand SE
    J Med Assoc Ga; 1972 Mar; 61(3):99-106. PubMed ID: 4551367
    [No Abstract]   [Full Text] [Related]  

  • 29. Enzyme defects in hereditary porphyria.
    Civin WH; Epstein E
    Ann Clin Lab Sci; 1980; 10(5):395-401. PubMed ID: 6999973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute hepatic porphyrias.
    Brodie MJ; Goldberg A
    Clin Haematol; 1980 Jun; 9(2):253-72. PubMed ID: 7398148
    [No Abstract]   [Full Text] [Related]  

  • 31. Hepatic -aminolaevulinic acid synthetase activity in porphyria cutanea tarda.
    Moore MR; Turnbull AL; Barnardo D; Beattie AD; Magnus IA; Goldberg A
    Lancet; 1972 Jul; 2(7768):97-100. PubMed ID: 4113925
    [No Abstract]   [Full Text] [Related]  

  • 32. Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria.
    Pimstone NR; Blekkenhorst G; Eales L
    Enzyme; 1973; 16(1):354-66. PubMed ID: 4791054
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent advances in porphyrin metabolism.
    Pindyck J; Kappas A; Levere RD
    CRC Crit Rev Clin Lab Sci; 1971; 2(4):639-57. PubMed ID: 4944524
    [No Abstract]   [Full Text] [Related]  

  • 34. Experimental porphyria. II. Drug-induced porphyrin biosynthesis.
    Creighton JM; Racz WJ; Tyrrell DL; Schneck DW; Marks GS
    S Afr Med J; 1971 Sep; ():79-81. PubMed ID: 5150298
    [No Abstract]   [Full Text] [Related]  

  • 35. Aetiological relationship between hepatic siderosis and symptomatic porphyria cutanea tarda. Evidence based on work in Durban.
    Joubert SM; Taljaard JJ; Shanley BC
    Enzyme; 1973; 16(1):305-13. PubMed ID: 4133881
    [No Abstract]   [Full Text] [Related]  

  • 36. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis.
    Meyer UA
    Enzyme; 1973; 16(1):334-42. PubMed ID: 4791052
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: Hematin and porphyria.
    Watson CJ
    N Engl J Med; 1975 Sep; 293(12):605-7. PubMed ID: 1152896
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute intermittent porphyria].
    Catania A; Caimi G
    Minerva Med; 1983 Nov; 74(43):2605-9. PubMed ID: 6657112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hepatic porphyrias].
    Crispin M; Szeinberg A
    Harefuah; 1972 Feb; 82(3):137-9. PubMed ID: 4565661
    [No Abstract]   [Full Text] [Related]  

  • 40. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.
    Abbritti G; De Matteis F
    Chem Biol Interact; 1972 Mar; 4(4):281-6. PubMed ID: 5008942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.